By doing so, they occupy the ligand-binding pocket of PD-1, preventing PD-L1/PD-L2 (expressed on tumor or immune cells) from interacting with PD-1 and effectively blocking inhibitory signal transmission. This evidence concerns the gene PDCD1LG2 and neoplasm.